PHAT

PharmAthene, Inc.

Application Filed: 2009-10-28
Trademark Application Details
Trademark Logo PHAT
602
Dead/Abandoned
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Research OneLook Acronym Finder
Serial Number77859670
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney NameJoel N. Bock
Attorney Docket Number80000196-000
Law Office AssignedL90
Employee NameANKRAH, NAAKWAMA S

Timeline

2009-10-28Application Filed
2010-08-06Abandon
2010-09-08Location: TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
2010-09-08Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Applicants & Owners

Owner: PharmAthene, Inc.
AddressOne Park Place, Suite 450 Annapolis DE 21401
Legal Entity TypeCorporation
Legal Entity StateDE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

JOEL N. BOCK
SONNENSCHEIN NATH & ROSENTHAL LLP
PO BOX 061080
CHICAGO, IL 60606-1080

Good, Services, and Codes

International Codes:9
U.S. Codes:021,023,026,036,038
Type CodeType
GS0091Pharmaceutical preparations for counteracting the effects of biological and chemical agents; pharmaceutical preparations for treating infectious diseases; antibody based pharmaceutical preparations for counteracting the effects of biological and chemical agents; antibody based pharmaceutical preparations for treating infectious diseases; vaccines; pharmaceutical preparations for treatment and prevention of Alzheimer's disease; pharmaceutical preparations for treatment and prevention of poisoning; pharmaceutical preparations for treatment and prevention of neurological disease; pharmaceutical preparations for treatment and prevention of infectious disease; recombinant based therapeutics in the nature of pharmaceutical preparations for counteracting the effects of biological and chemical agents and for treating infectious diseases; pharmaceutical preparations acting on the central nervous system for counteracting the effects of biological and chemical agents and for treating infectious diseases; pharmaceutical preparations for treatment and prevention of anthrax infection; pharmaceutical preparations for treatment and prevention of toxicity caused by cholinesterase inhibiting compounds

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2009-10-311 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2009-11-042 NWOS I:Incoming Correspondence
NOTICE OF PSEUDO MARK MAILED2009-11-053 MPMK O:Outgoing Correspondence
ASSIGNED TO EXAMINER2010-02-014 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2010-02-055 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2010-02-056 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED2010-02-057 GNRN O:Outgoing Correspondence
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE2010-09-088 ABN2 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND2010-09-099 MAB2 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed